一种用于胎儿血红蛋白诱导的WIZ转录因子的分子降解剂
Pamela Y Ting1, Sneha Borikar1, John Ryan Kerrigan1
1Novartis Biomedical Research, Cambridge, MA, USA.
概括
研究人员发现了新的分子,dWIZ-1和dWIZ-2,可以降解WIZ蛋白质. 这种降解有效地诱导红细胞中的胎儿血红蛋白 (HbF),为状细胞疾病 (SCD) 提供了一个有希望的新治疗策略.
科学领域:
- 遗传学和分子生物学
- 血液学
- 药物发现
背景情况:
- 状细胞病 (SCD) 是一种严重的遗传性血液疾病,由β-血红蛋白突变引起.
- 诱导胎儿血红蛋白 (HbF) 是治疗SCD并发症的一个目标.
- 现有的小分子HbF诱导剂缺乏足够的安全性和有效性.
研究的目的:
- 确定状细胞疾病的新疗法.
- 发现可以安全有效地诱导胎儿血红蛋白 (HbF) 的小分子.
主要方法:
- 一个Cereblon (CRBN) 偏差化学库的表型选.
- 发现和描述dWIZ-1和dWIZ-2分子降解剂.
- 三元复合体的晶体分析.
- 在人性化小鼠和子中进行的体内研究.
主要成果:
- 确定dWIZ-1和dWIZ-2是WIZ转录因子的分子降解剂.
- 发现WIZ是一种新的胎儿血红蛋白 (HbF) 表达抑制剂.
- 在红色细胞中强烈诱导WIZ降解HbF.
- 在临床前模型中,药理性WIZ降解耐受性良好且有效.
结论:
- WIZ降解是一种新且有效的状细胞疾病治疗策略.
- dWIZ-1和dWIZ-2显示出作为安全有效的HbF诱导剂的潜力.
- 这种方法为SCD提供了全球可访问的治疗途径.
相关概念视频
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
General Transcription Factors
5.2K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
5.2K
Transcription Factors
75.8K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
75.8K
Chromatin Modification in iPS Cells
1.6K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.6K
Methods of Nuclear Reprogramming
1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
Eukaryotic Transcription Inhibitors
9.8K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.8K


